Диссертация (1145006), страница 43
Текст из файла (страница 43)
Dis. – 2009. – Vol. 19, Suppl. 2. – P. 11 – 14.267156. Cardio-renal syndromes: report from the consensus conference of the AcuteDialysis Quality Initiative /C. Ronco, P. McCullough, S. Anker [et al.] //Eur. HeartJ. – 2010. – Vol. 31. – P. 703 – 711.157. Choice оf GFR estimating equating influences dialysis initiation and mortality/B.Wilson, J.M. Sontrop, W.F. Clark [et al.] //Nephron Nurs. J. - 2013. - Vol. 40, №4. - P. 339 - 346.158. Chronic kidney disease as cause of cardiovascular morbidity and mortality /R.Vanholder, Z.
Massy, A. Argiles [et al.] //Nephrol. Dial. Transplant. - 2005, Jun. Vol. 20, № 6. - P. 1048 - 1056.159. Chronic Kidney Disease Associated Mortality in Diastolic Versus Systolic HeartFailure: A Propensity Matched Study /A. Ahmed, M.W. Rich, P.W. Sanders [et al.]//Am. J. Cardiol. - 2007.
- Vol. 99. - P. 393 – 398.160. Chronic Kidney Disease and the Risk for Cardiovascular Disease, RenalReplacement, and Death in the United States Medicare Population 1998 to 1999/R. Foley, A. Murray, S. Li [et al.] //J. Am. Soc. Nephrol. - 2005. – Vol. 16. – P.489 – 495.161. Chronic kidney disease and the risks of death, cardiovascular events, andhospitalization /A.S. Go, G.M. Chertow, D. Fan [et al //N. Engl. J. Med. - 2004. Vol. 351. - P.
1296 - 1305.162. CIN Consensus Working Panel: Risk prediction of contrast-induced nephropathy/P.A. McCullough, A. Adam, C.R. Becker [et al.] //Am. J. Cardiol. - 2006. - Vol. 98.- P. 27K-36K.163. CKD and cardiovascular disease in screened high-risk volunteer and generalpopulations: the Kidney Early Evaluation Program (KEEP) and National Health andNutrition Examination Survey (NHANES) 1999-2004 /P.A. McCullough, S. Li, C.T.Jurkovitz [et al.] //Am.
J. Kidney Dis. – 2008. – Vol. 51, № 4, Suppl. 2. - P. 38 –45.268164. Clerico, A. Cardiac endocrine function is an essential component of thehomeostatic regulation network: physiological and clinical implications /A. Clerico,F.A. Recchia, C. Passino //Amer. J. Physiol. – 2006. – Vol. 290. – P.
17–29.165. Cohn J.N. Bedside catheterization of the left ventricle /J.N. Cohn, I.M. Khatri ,P. Hamosh //Am. J. Cardiol. - 1970. - Vol. 25, №1. - P. 66 – 69.166. Contrastinduced nephropathy after percutaneous coronary interventions inrelation to chronic kidney disease and hemodynamic variables /G. Dangas, I.Iakovou, E. Nikolsky [et al.] //Am. J. Cardiol. - 2005. - Vol.
95. - P. 13-19.167. C-reactive protein is a potent predictor of mortality independently of and incombination with troponin T in acute coronary syndromes: a TIMI 11A substudy.Thrombolysis in Myocardial Infarction /D.A. Morrow, N. Rifai, E.M. Antman [etal.] //J.
Am. Coll. Cardiol. - 1998. - 31. - P. 1460 – 1465.168. Cyctatin C associates with the pre-diction of in-stent restenosis among pacientrecerving stent implantation: results of the 1-year follow-up /C. Zhao, L. Yang, L.Mao [et al.] //Coron. Artery Diss. - 2013. – Vol. 24, № 5. - P.
357 - 360.169. Cytokin-induced VCAM-1 and ICAM-1 expression in different organs of mouse/D.D. Henninger, J. Panes, M. Eppihimer [et al.] //The J. of Immunology. – 1997. –Vol. 158, № 4. – P. 1825 - 1832.170. Decker, K. Biologically active products of stimulated liver macrophags (Kupffercells) /K. Decker //Eur.
J. Biochem. – 1990. – Vol. 192, № 2. – P. 245 - 261.171. Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes,1999-2006 Eagle for the GRACE Investigators /К.A.A. Fox, P.G. Steg, К.A. [etal.] //JAMA. – 2007. - Vol. 297. - P. 1892 - 1900.172. De Geus, H.R.H. Biomarkers for the prediction of acute kidney injury: a narrativereview on current status and future challenges /H.R.H. De Geus, M.
G. Betjes, J.Bakker //Clin. Kidney J. -2 April. - Vol. 5, № 2. - P. 102 - 108.173. De Lemos, J.A. B–type natriuretic peptide in cardiovascular disease /J.A. DeLemos, D.K. McGuire, M.H. Drazner //The Lancet. – 2003.- № 363. – Р.316 - 322.269174. Despres, J.-P. Abdominal obesity: the most prevalent cause of the metabolicsyndrome and related cardiometabolic risk /J.-P. Despres //Eur.
Heart J. - 2006. Vol. 8, Suppl. B. - B4 – B12.175. Devarajan, P. Biomarkers for the Early Detection of Acute Kidney Injury /P.Devarajan //Curr. Opin. Pediatr. - 2011 April. - Vol. 23, № 2. - P. 194 - 200.176. Devarajan, P. Neutrophil gelatinase-associated lipocalin: a promising biomarkerfor human acute kidney injury /P. Devarajan //Biomark. Med. - 2010 April. - Vol.4, № 2. - P. 265 - 280.177. Devarajan, P. Neutrophil gelatinase-associated lipocalin (NGAL): a new markerof kidney disease /P. Devarajan //Scand. J. Clin.
Lab. Invest. - 2008. - Vol. 68. - P.89 - 94.178. Does simplicity compromise accuracy in ACS risk prediction? A retrospectiveanalysis of the TIMI and GRACE risk scores. Abstract /K.G. Aragam, U.U.Tamhane, E. Kline-Rogers [et al.] // PLoS One. - 2009. – Vol. 4.
- e7947.179. Early and long-term clinical outcomes associated with reinfarction followingfibrinolytic administration in the Thrombolysis in Myocardial infarction trials /C.M.Gibson, J. Karha, S.A. Murphy [et al.] //J. Am. Coll. Cardiol. – 2003. – Vol.
42. - P.7 - 16.180. Efficacy and safety of enoxaparin compared with unfractionated heparin in highrisk patients with non–ST-segment elevation acute coronary syndrome undergoingpercutaneous coronary intervention in the Superior Yield of the New Strategy ofEnoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY)trial /H.D. White, N.S. Kleiman,K.W. Mahaffey[et al.] //AmericanHeardJournal. - 2006. - Vol. 152, Issue 6. - P. 1042 - 1050.181. Emergency room triage of patients with acute chest pain by means of rapidtesting for cardiac troponin T or troponin I /C.W.
Hamm, B.U. Goldmann, C.Heeschen [et al.] //N. Engl. J. Med. - 1997. - Vol . 337. - P. 1648 – 1653.270182. Endothelial cells in Physiology and in the Pathophysiology of Vascular Disorders/D.B. Cines, E.S. Pollak, C.A. Buck [et al.] //Blood. – 1998. – Vol. 91, № 10. – P.3527 - 3561.183. ESC Guidelines for the management of acute coronary syndromes in patientspresenting withoutpersistentST- segment /C.W. Hamm , J.-P. Bassand , S.Agewall [et al.] //European Heart Journal.
- 2011. - Vol. - 32. - P. 2999 - 3054.184. Evaluation of the association between the first observation and the longitudinalchange in C-reactive protein, and all-cause mortality /C.J. Currie, C.D. Poole, P.Conway [et al.] //Heart. - 2008. - Vol. 94. - P. 457 – 462.185. Euro Heart Survei Investigators. Тhe prevalence of abnormal glucose regulationin patients with coronary artery disease across Europe /М.
Bartnik, L. Ryden, R.Ferrari [et al.] //Eur. Heart J. - 2004. - Vol. 25. - P. 1880 - 1890.186. Fasting glucose is an important independent risk factor for 30-day mortality inpatients with acute myocardial infarction: a prospective study /M. Suleiman, H.Hammerman, M. Boulos [et al.] //Circulation.- 2005. - Vol. 111. - P. 754 – 760.187. Foley, R.N. Clinical epidemiology of cardiovascular disease in chronic renaldisease /R.N. Foley, P.S. Parfrey, M.J.
Sarnak //Am. J. Kidney Dis. – 1998. –Vol. 32. – P. 112 – 119.188. Gender perspective on risk factors, coronary lesions and long-term outcome inyoung patients with ST- elevation myocardial infarction /S.S. Lawesson, U.Stenestrand, B. Lagergvist [et al.] //Heart. – 2010. – Vol. 96, № 6. – P. 453 – 459.189. Geus, H. Biomarkers for the prediction of acute kidney injury: a narrative reviewon current status and future challenges /M. Betjes, J.
Bakker //Clin. Kidney J. –2012. - Vol. 5. - № 2. - P.102 - 108.190. Godwin, J.G. Identification of a micro RNAsignature ofrenal ischemiareperfusion injury /X. Ge, K. Stephan //Proc. Natl. Acad. Sci. – 2010. –Vol.107. - №32. – P. 14339 - 14344.191. Guidelines for percutaneous transluminal coronary angioplasty. A report of theAHA/ACC Task force on assessment of diagnostic and therapeutic cardiovascularprocedures (Committee on percutaneous transluminal coronary angioplasty) /T.J.271Ryan, W.B. Bauman, J.W.
Kennedy [et al] //Circulation. – 1993. – Vol.88, Iss. 6. –P. 2987–3007.192. Heart disease and stroke statistics--2014 update: a report from the AmericanHeart Association /A.S. Go, D. Mozaffarian, V.L. Roger [et al.] //Circulation. –2014. – Vol. 129. - № 3. – P. e28 - e292.193. Heart disease and stroke statistics – 2013 update: a report from the AmericanHeart Association [Электpoнный pеcуpc] /A.S. Go, D. Mazzafarian, V.L. Roger [etal.]. – URL: http://circ.ahajournals.org/content/127/1/143.full.pdf+html (Дaтaoбpaщения: 11.04.2015)].194. Heart disease and stroke statistics – 2011 update: a report from the AmericanHeart Association /V.L.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
